logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 9
  • 1
    Stevens, Josephine Angela
    Individual (1 offspring)
    Officer
    2022-07-19 ~ now
    OF - Secretary → CIF 0
  • 2
    Foy, Matthew
    Biotech Venture Capital born in April 1980
    Individual (9 offsprings)
    Officer
    2017-09-05 ~ 2025-08-06
    OF - Director → CIF 0
  • 3
    Novak, Rodger, Dr
    Born in June 1967
    Individual (6 offsprings)
    Officer
    2020-04-27 ~ now
    OF - Director → CIF 0
    Mr Rodger Novak
    Born in June 1967
    Individual (6 offsprings)
    Person with significant control
    2020-04-28 ~ 2021-04-19
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 4
    Foy, Shaun Patrick
    Born in February 1970
    Individual (7 offsprings)
    Officer
    2017-02-10 ~ now
    OF - Director → CIF 0
    Shaun Patrick Foy
    Born in February 1970
    Individual (7 offsprings)
    Person with significant control
    2017-02-10 ~ 2021-04-19
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 5
    George, Simeon John
    Born in March 1977
    Individual (3 offsprings)
    Officer
    2017-09-05 ~ now
    OF - Director → CIF 0
  • 6
    Goldsmith, Bruce
    Chief Executive Officer born in December 1965
    Individual (1 offspring)
    Officer
    2023-04-27 ~ 2023-12-14
    OF - Director → CIF 0
  • 7
    Kudari, Mahesh
    Born in July 1984
    Individual (4 offsprings)
    Officer
    2025-08-06 ~ now
    OF - Director → CIF 0
  • 8
    GLAXOSMITHKLINE FINANCE PLC
    - now 00242686
    SMITHKLINE BEECHAM FINANCE P.L.C. - 2001-10-01
    BEECHAM FINANCE P L C - 1989-10-03
    BEECHAM FOODS LIMITED - 1980-12-31
    980, Great West Road, Brentford, Middlesex, United Kingdom
    Active Corporate (21 parents, 12 offsprings)
    Person with significant control
    2020-07-29 ~ 2020-09-17
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 9
    OAKWOOD CORPORATE SECRETARY LIMITED
    07038430
    3rd Floor, 1 Ashley Road, Altrincham, Cheshire, United Kingdom
    Active Corporate (7 parents, 3525 offsprings)
    Officer
    2020-07-29 ~ 2022-07-19
    OF - Secretary → CIF 0
parent relation
Company in focus

XAP THERAPEUTICS LIMITED

Period: 2021-07-20 ~ now
Company number: 10613866
Registered names
XAP THERAPEUTICS LIMITED - now
ROCKEND LIMITED - 2021-07-20
Standard Industrial Classification
64303 - Activities Of Venture And Development Capital Companies
Brief company account
Please be reminded the displayed account data is older than 4 years hence might not reflect current company status.
Average Number of Employees
02019-03-01 ~ 2019-12-31
02018-03-01 ~ 2019-02-28
Par Value of Share
Class 1 ordinary share
02019-03-01 ~ 2019-12-31
Debtors
28,077 GBP2019-12-31
5,442 GBP2019-02-28
Cash at bank and in hand
204,764 GBP2019-12-31
183,600 GBP2019-02-28
Current Assets
232,841 GBP2019-12-31
189,042 GBP2019-02-28
Creditors
Current
59,870 GBP2019-12-31
32,898 GBP2019-02-28
Net Current Assets/Liabilities
172,971 GBP2019-12-31
156,144 GBP2019-02-28
Total Assets Less Current Liabilities
172,971 GBP2019-12-31
156,144 GBP2019-02-28
Creditors
Non-current
379,219 GBP2019-12-31
263,396 GBP2019-02-28
Net Assets/Liabilities
-206,248 GBP2019-12-31
-107,252 GBP2019-02-28
Equity
Called up share capital
10 GBP2019-12-31
10 GBP2019-02-28
Retained earnings (accumulated losses)
-206,258 GBP2019-12-31
-107,262 GBP2019-02-28
Equity
-206,248 GBP2019-12-31
-107,252 GBP2019-02-28
Other Debtors
Current
4,930 GBP2019-12-31
10 GBP2019-02-28
Amount of corporation tax that is recoverable
Current
12,553 GBP2019-12-31
Amount of value-added tax that is recoverable
Current
10,594 GBP2019-12-31
5,432 GBP2019-02-28
Debtors
Amounts falling due within one year, Current
28,077 GBP2019-12-31
Current, Amounts falling due within one year
5,442 GBP2019-02-28
Trade Creditors/Trade Payables
Current
11,597 GBP2019-12-31
1,475 GBP2019-02-28
Accrued Liabilities
Current
48,273 GBP2019-12-31
31,423 GBP2019-02-28
Other Remaining Borrowings
Non-current
379,219 GBP2019-12-31
263,396 GBP2019-02-28
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
1,000,000 shares2019-12-31
Profit/Loss
Retained earnings (accumulated losses)
-98,996 GBP2019-03-01 ~ 2019-12-31

  • XAP THERAPEUTICS LIMITED
    Info
    ROCKEND LIMITED - 2021-07-20
    Registered number 10613866
    Babraham Research Campus, Maia Building (b270), Cambridge CB22 3AT
    PRIVATE LIMITED COMPANY incorporated on 2017-02-10 (9 years 1 month). The status of the company number is Active.
    The last date of confirmation statement was made at 2026-02-09
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 March 2026 and licensed under the Open Government Licence v3.0.